Country: Australia
Bahasa: Inggeris
Sumber: Department of Health (Therapeutic Goods Administration)
albendazole, Quantity: 400 mg
Aspen Pharmacare Australia Pty Ltd
Tablet, chewable
Excipient Ingredients: povidone; sodium lauryl sulfate; saccharin sodium; lactose monohydrate; croscarmellose sodium; microcrystalline cellulose; magnesium stearate; maize starch; sunset yellow FCF aluminium lake; Flavour
Oral
60 tablets
(S4) Prescription Only Medicine
HYDATID DISEASE: Albendazole is indicated for the treatment of hydatid cysts caused by E. granulosus in adults and children over 6 years of age, where surgical intervention is not feasible because of anatomic site or the presence of multiple cysts. Albendazole shows greatest efficacy in the treatment of liver, lung and peritoneal cysts. Experience with bone cysts or those in the heart or central nervous system is limited, but cases of successful treatment with prolonged course of albendazole have been reported. Albendazole may also be used as an adjunct to surgical excision of hydatid cysts either: 1) prior to surgical intervention, or 2) post-operatively, if pre-operative treatment was too short (less than two separate 28-day cycles) or if viable cysts are found at surgery. LARVAL TAENIASIS (NEUROCYSTICERCOSIS): Albendazole is effective in the treatment of neurocysticercosis (NCC) in courses as short as 7 days. OTHER INDICATIONS: There is also evidence that albendazole is effective against Capillaria philippinensis in courses of 10 days.
Visual Identification: Mottled pale orange rounded oblong biconvex tablets with a score line on one side and embossed "ALB400" on the reverse, with a characteristic fruity odour.; Container Type: Bottle; Container Material: HDPE; Container Life Time: 5 Years; Container Temperature: Store below 30 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert
Registered
2003-10-09
ESKAZOLE 1 ESKAZOLE _albendazole _ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about ESKAZOLE. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the possible risks of taking ESKAZOLE against the expected benefits. If you have any concerns about taking this medicine talk to your doctor or pharmacist. Keep this leaflet with this medicine. You may need to read it again. WHAT IS ESKAZOLE USED FOR? ESKAZOLE contains albendazole as the active ingredient. ESKAZOLE is used to clear worms or parasites from the gut and other tissues. ESKAZOLE is effective in a number of different conditions caused by parasites including hydatid disease and neurocysticercosis. ESKAZOLE is thought to kill these parasites by causing them to starve. The eggs, larvae and adult parasites are affected. Your doctor may have prescribed ESKAZOLE for another reason. Ask your doctor if you have any questions about why ESKAZOLE has been prescribed for you. There is no evidence that ESKAZOLE is addictive. BEFORE YOU TAKE ESKAZOLE _DO NOT TAKE IF: _ • you have had an allergic reaction to albendazole or any of the other ingredients contained in this medicine. Albendazole is also contained in ZENTEL. The ingredients are listed at the end of this leaflet. Signs of an allergic reaction may include an itchy skin rash, shortness of breath and swelling of the face or tongue. • if you have taken albendazole before and became unwell, tell your doctor or pharmacist before taking the first dose. • you are allergic to medicines similar to albendazole such as mebendazole (Sqworm or Vermox) or thiabendazole (Mintezol). • YOU KNOW OR SUSPECT YOU ARE PREGNANT. Pregnancy must be avoided (ie use effective contraceptive measures) during treatment, and for one month after stopping ESKAZOLE. • YOU ARE BREAST FEEDING. Your baby can absorb albendazole from breast milk if you ar Baca dokumen lengkap
Eskazole-pi-feb2020 1 AUSTRALIAN PRODUCT INFORMATION ESKAZOLE (ALBENDAZOLE) CHEWABLE TABLETS 1 NAME OF THE MEDICINE Albendazole. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each ESKAZOLE tablet contains albendazole 400 mg as the active ingredient. List of excipients with known effect include lactose monohydrate and saccharin sodium. For the full list of excipients, see Section 6.1 LIST OF EXCIPIENTS. 3 PHARMACEUTICAL FORM ESKAZOLE 400mg chewable tablets are a mottled, pale orange, rounded oblong, biconvex, tablets with a score line on one side and engraved ALB 400 on the other. ESKAZOLE tablets have a distinctive fruity odour. 4 CLINICAL PARTICULARS 4.1 T HERAPEUTIC INDICATIONS Hydatid Disease The long term use of ESKAZOLE is indicated for the treatment of hydatid cysts caused by _ E. _ _granulosus_ in adults and children over 6 years of age, where surgical intervention is not feasible because of anatomic site or the presence of multiple cysts. Albendazole shows greatest efficacy in the treatment of liver, lung and peritoneal cysts. Experience with bone cysts or those in the heart or central nervous system is limited, but cases of successful treatment with a prolonged course of albendazole have been reported. ESKAZOLE may also be used as an adjunct to surgical excision of hydatid cysts either: 1) prior to surgical intervention, or 2) post-operatively, if pre-operative treatment was too short (less than two separate 28- day cycles) or if viable cysts are found at surgery. Larval Taeniasis (Neurocysticercosis) ESKAZOLE is effective in the treatment of neurocysticercosis (NCC) in courses as short as 7 days. Other Indications There is also evidence that ESKAZOLE is effective against _Capillaria philippinensis_ in courses of 10 days. Eskazole-pi-feb2020 2 4.2 D OSE AND METHOD OF ADMINISTRATION ESKAZOLE 400mg chewable tablets may be crushed, chewed, or swallowed whole. Some people, particularly young children, may experience difficulties swallowing the tablets whole and should be encouraged to chew the tablets with a li Baca dokumen lengkap